Drug interactions
Ipratropium-salbutamol + Triptorelin
Severity: Minor
Ipratropium-salbutamol and Triptorelin: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Triptorelin, an androgen-deprivation therapy, may prolong the QT interval, and salbutamol can cause tachycardia and hypokalemia that favour arrhythmia. The combined effect is generally small at usual inhaled doses but matters in patients with other QT risk factors.
What this interaction means in plain words
Ipratropium-salbutamol and Triptorelin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Ipratropium-salbutamol belongs to Respiratory; Triptorelin belongs to Endocrine.
Why it happens
Androgen deprivation-related QT prolongation combined with beta2-agonist-induced tachycardia and hypokalemia.
What to do
Correct potassium and magnesium abnormalities and consider an ECG in patients with other QT risk factors or heavy salbutamol use.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ipratropium-salbutamol and Triptorelin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ipratropium-salbutamol
Other interactions of Triptorelin
Frequently asked questions
Can I take Ipratropium-salbutamol with Triptorelin?
MediHelp rates the interaction as minor. Ipratropium-salbutamol and Triptorelin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Triptorelin, an androgen-deprivation therapy, may prolong the QT interval, and salbutamol can cause tachycardia and hypokalemia that favour arrhythmia. The combined effect is generally small at usual inhaled doses but matters in patients with other QT risk factors.
How serious is the interaction between Ipratropium-salbutamol and Triptorelin?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Correct potassium and magnesium abnormalities and consider an ECG in patients with other QT risk factors or heavy salbutamol use.
What other medicines interact with Ipratropium-salbutamol?
MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
